hoodb.com

2024BIO廠商快訊——安成生技全球首個遺傳型 EB新藥AC-203進行多國三期臨床

|

You are leaving and open the following URL" of about "eb" news

news.google.com/rss/articles/CBMibkFVX3lxTFByRkk1RGZxYm9OaWN0d3BsVWREbDdnWVJUQTFQdzB1TkRadTdrMlBMVk5ReENLNGJWNlkybFVuaDExWTRTZ0hHQThWam1ydU1YR3FER0xYQnNDZm5aZUFWM1pTay1RR3BUUjM2NjN3?oc=5


Continue Opne >

eb: 2024BIO廠商快訊——安成生技全球首個遺傳型 EB新藥AC-203進行多國三期臨床


More eb news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/NO/eb.xml in /var/www/hoodb/function.php on line 339
1736579189-
Warning: file_put_contents(aCache/aaa/gnews/NO//eb.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About eb

from
1736579190-1736280991

Warning: filemtime(): stat failed for aCache/search/no/eb in /var/www/hoodb/function.php on line 339
1736579190-

eb, 2024BIO廠商快訊——安成生技全球首個遺傳型 EB新藥AC-203進行多國三期臨床 2022 eb

2024BIO廠商快訊——安成生技全球首個遺傳型 EB新藥AC-203進行多國三期臨床

Choose Your Country or Region


Back to Top



2024BIO廠商快訊——安成生技全球首個遺傳型 EB新藥AC-203進行多國三期臨床

Copyright © 2020-2021 hoodb.com. All Rights Reserved.